These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 15532464)

  • 21. [Characteristics of the nature and dynamics of neuropsychic disorders in patients with newly detected pulmonary tuberculosis undergoing intensive chemotherapy].
    Immerman KL; Pankratova LE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(6):109-13. PubMed ID: 3188739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of pulmonary tuberculosis in patients with drug dependence].
    Zadremaĭlova TA; Aksenova KI
    Probl Tuberk Bolezn Legk; 2003; (7):31-3. PubMed ID: 12939874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of patients with destructive pulmonary tuberculosis with concomitant diabetes mellitus].
    Giller DB; Kostenko AD; Giller BM; Giller GV
    Probl Tuberk; 2002; (11):18-21. PubMed ID: 12501789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of tuberculosis cases detected in our region between 1999 and 2003].
    Ozbay B; Sezgi C; Altinöz O; Sertoğullarindan B; Tokgöz N
    Tuberk Toraks; 2008; 56(4):396-404. PubMed ID: 19123075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics and causes of the torpid (lingering) course of intrathoracic tuberculosis in children, the specific features of chemotherapy and outcomes].
    Iukhimenko NV; Elufimova VF; Mitinskaia LA
    Probl Tuberk Bolezn Legk; 2006; (8):29-33. PubMed ID: 17002055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Failures of standardized treatments in pulmonary tuberculosis. Possibilities of prevention and therapeutic recovery].
    Sava N; Stanca-Circioiu M; Gartner A; Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):165-72. PubMed ID: 6273988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis].
    Navrotskiĭ VV; Pertsovskiĭ AI; Belogurova VP
    Probl Tuberk; 1968; 46(11):39-43. PubMed ID: 5711714
    [No Abstract]   [Full Text] [Related]  

  • 28. [Psychosomatic factors in the treatment of pulmonary tuberculosis].
    Pecyna MB
    Pol Tyg Lek; 1989 Jan 9-16; 44(2-3):55-7. PubMed ID: 2798208
    [No Abstract]   [Full Text] [Related]  

  • 29. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Leukergy in patients with pulmonary tuberculosis treated for the first time with antitubercular drugs].
    Przemyska B
    Gruzlica; 1967; 35(11):1169-74. PubMed ID: 6063620
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical and social aspects of chronic pulmonary tuberculosis in Finland.
    Tani P
    Scand J Respir Dis Suppl; 1970; 72():93-105. PubMed ID: 5273228
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment with antibacterial preparations and tuberculin of patients with destructive forms of pulmonary tuberculosis].
    Rakhmanov KhKh
    Vrach Delo; 1967 May; 5():83-7. PubMed ID: 5618552
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficiency treatment of new cases of destructive pulmonary tuberculosis in the presence of concurrent iron deficiency anemia].
    Voloshina VV; Fomicheva NI
    Probl Tuberk; 2002; (2):10-2. PubMed ID: 11899794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proceedings: The problem of recurrences in pulmonary tuberculosis].
    Anastasatu C; Mihăilescu P; Plopeanu D
    Ftiziologia; 1974; 23(1):25-30. PubMed ID: 4822457
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sociomedical factors influencing mortality in patients with tuberculosis].
    Frolova IA
    Probl Tuberk Bolezn Legk; 2004; (3):10-3. PubMed ID: 15338891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.
    Okanurak K; Kitayaporn D; Wanarangsikul W; Koompong C
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):762-8. PubMed ID: 17609051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
    Chukanov VI; Kaminskaia GO; Livchane E
    Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A paradoxical reaction during antituberculosis therapy for congenital tuberculosis.
    Park JA; Park SS; Park SE
    Int J Infect Dis; 2009 Sep; 13(5):e279-81. PubMed ID: 19124260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of bacteriological examinations of tissue specimens from patients dead of tuberculosis. Attempt at evaluation of treatment failures].
    Owsiński J; Korlakowski J
    Gruzlica; 1971 Aug; 39(8):774-82. PubMed ID: 5097538
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical pattern of tuberculosis in patients with mental disorders in Sverdlovsk region].
    Eĭsmont NV
    Probl Tuberk; 2000; (3):15-6. PubMed ID: 10900976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.